29
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8682 |
Vazegepant hydrochloride
Vazegepant HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Vazegepant hydrochloride (Vazegepant HCl) 是一种用于偏头痛的鼻用 gepant,是一种高度亲和性CGRP 受体拮抗剂 (hCGRPKi=0.023 nM)。它可能有助于有效管理 COVID-19 相关肺部炎症。 | |||
T17194 |
Ubrogepant
MK-1602 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。 | |||
TP1040 |
Calcitonin (salmon)
鲑降钙素,Calcitonin salmon,Salmon calcitonin |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Calcitonin (salmon) 是一种阿米林和卡西宁受体的双激动剂,是一种钙调节激素,能够刺激骨的生成并能抑制骨吸收。 | |||
T12293L |
Olcegepant
BIBN-4096,BIBN 4096BS |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Olcegepant (BIBN-4096) 是一种选择性的降钙素基因相关肽1 (CGRP1) 受体拮抗剂,IC50=0.03 nM,Ki=14.4 pM。 | |||
T4610 |
Rimegepant
BMS 927711,BMS-927711,BMS927711,BHV-3000 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Rimegepant (BMS 927711) 是一种有效的降钙素基因相关肽 (CGRP) 受体拮抗剂,其 Ki=0.027 nM,IC50=0.14 nM。 | |||
T6590 |
MK-3207 Hydrochloride
MK-3207 HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
MK-3207 Hydrochloride (MK-3207 HCl) 是口服具有活力的CGRP receptor 拮抗剂,IC50=0.12 nM,Ki=0.024 nM。 | |||
T13453 |
CGRP antagonist 1
|
CGRP Receptor | GPCR/G Protein; Neuroscience |
CGRP antagonist 1是高效 CGRP 受体拮抗剂,Ki 值分别为 35nM,IC50 值为 57 nM。CGRP antagonist 1可用于研究心血管疾病和神经血管疾病。 | |||
TP1323 |
CGRP 8-37 (rat)
|
CGRP Receptor | GPCR/G Protein; Neuroscience |
CGRP 8-37 (rat) 是 CGRP receptor 拮抗剂,是一种可作用于大鼠的 CGRP片段,具有潜在的抗伤害作用,可诱导动脉松弛。 | |||
TP1134L |
HCGRP-(8-37) acetate
HCGRP-(8-37) acetate (119911-68-1 free base) |
CGRP Receptor | GPCR/G Protein; Neuroscience |
HCGRP-(8-37) acetate 是一种人降钙素基因相关肽 (hCGRP) 片段醋酸盐,也是 CGRP 受体的拮抗剂。 | |||
TP1200 |
CGRP (83-119), rat TFA
Calcitonin Gene Related Peptide(83-119), rat TFA |
Others | Others |
CGRP (83-119), rat TFA (Calcitonin Gene Related Peptide(83-119), rat TFA) 是一种由 37 个氨基酸组成的神经肽降钙素家族,通过降钙素受体样受体起作用。 | |||
TP1257L |
Adrenomedullin (AM) (22-52), human acetate
Adrenomedullin (AM) (22-52), human acetate(159899-65-7 Free base) |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Adrenomedullin (AM) (22-52), human acetate 是猫后肢血管床中 CGRP 受体和肾上腺髓质素受体的拮抗剂。 | |||
T75978 |
β-CGRP, human TFA
|
||
β-CGRP, human TFA (Human β-CGRP TFA) 是一种降钙素肽,通过降钙素受体样受体CRLR 与RAMP 的复合物起作用,在细胞体系中,对 CRLR/RAMP1 和 CRLR/RAMP2 的IC50值分别为 1 nM 和 300 nM。 | |||
T30537 |
BMS-694153
BMS694153,BMS 694153 |
||
BMS-694153 is a potent and selective CGRP receptor antagonist. | |||
TP1134 |
HCGRP-(8-37)
Human α-CGRP (8-37) |
||
Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist | |||
T70820 |
MK-8825
|
||
MK-8825 is a CGRP receptor antagonist. | |||
T16093 |
Telcagepant
MK-0974 |
Others | Others |
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). | |||
T39522 |
HTL22562
|
||
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine. | |||
T38734 |
Vazegepant
Zavegepant,BHV-3500 |
||
Vazegepant is an intranasal CGRP receptor antagonist utilized for conducting acute migraine research. | |||
TP2044 |
α-CGRP(human)
α-CGRP (human) |
||
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist. | |||
T76363 |
[Tyr22] Calcitonin Gene Related Peptide, (22-37), rat
|
||
[Tyr22]CalcitoninGene Related Peptide, (22-37), rat 是一种大鼠降钙素基因相关肽 (CGRP) 的 22-37 片段,靶向CGRP 受体和腺苷酸环化酶。降钙素 (calcitonin) 主要由甲状腺 C 细胞产生,而 CGRP 则分泌并储存在神经系统中。 | |||
T26796 |
BI-44370
|
||
BI-44370, a CGRP (calcitonin gene-related peptide) receptor antagonist, can be used to treat migraines and other chronic pain. | |||
T12293 |
Olcegepant hydrochloride
BIBN-4096 hydrochloride,BIBN4096BS hydrochloride |
Others | Others |
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). | |||
TP1203 |
CGRP(83-119), rat
Calcitonin Gene Related Peptide (CGRP) (83-119), rat |
||
Calcitonin Gene Related Peptide (CGRP) (83-119), rat is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. | |||
TP2049 |
CRSP-1
|
||
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin recept | |||
T21558 |
MK-3207
|
||
MK-3207是口服生物相容性的CGRP 受体拮抗剂,IC50和 Ki 分别为 0.12 nM 和 0.024 nM,对 AM1,AM2,CTR 和 AMY3 的抑制性较弱。MK-3207可用于偏头痛研究。 | |||
T73703 | (3R,5R,6S)-Atogepant | ||
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) 是Atogepant 的异构体.Atogepant 是降钙素基因相关肽受体 (CGRP) 拮抗剂。Atogepant 可用于研究偏头痛。 | |||
TP1131 |
β-CGRP, human TFA (101462-82-2 free base)
CGRP-II (Human) (TFA),Human β-CGRP (TFA),β-CGRP, human TFA |
||
β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and CRLR/RAMP2 cells. | |||
T76678 | Eptinezumab | ||
Eptinezumab为人源化单克隆抗体,主要通过与降钙素基因相关肽(CGRP)结合,进而阻止其与受体相结合,用于成人偏头痛的预防。 | |||
T75934 |
AC 187 TFA
|
||
AC 187 TFA 是一种有效且具有口服活性的胰淀素受体 (amylin receptor) 拮抗剂,IC50为 0.48 nM,Ki 为 0.275 nM。AC 187 TFA 对胰淀素受体的选择性高于降钙素和 CGRP 受体。AC 187 TFA 具有神经保护作用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21581L |
AC 187 Acetate
AC 187 Acetate (151804-77-2 Free base) |
Amylin Receptor | GPCR/G Protein |
AC 187 Acetate 是胰淀素受体的强效拮抗剂。AC 187 对胰淀素受体的选择性高于降钙素和 CGRP 受体。 | |||
TP2167 |
β-CGRP, human acetate
β-CGRP, human acetate (101462-82-2 free),CGRP-II (Human) (acetate),Human β-CGRP acetate |
CGRP Receptor | GPCR/G Protein; Neuroscience |
β-CGRP, human acetate 是降钙素肽之一,通过受体活性修饰蛋白 (RAMP) 和降钙素受体样受体 (CRLR) 的复合物发挥作用(对于 CRLR/RAMP1 和 CRLR,IC50:1 nM 和 300 nM /RAMP2 在单元格中)。 |